# Renal PK Study of LC350189

> **NCT04066712** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 37 (actual)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** LC350189 200 mg

## Key facts

- **NCT ID:** NCT04066712
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-19
- **Primary completion:** 2020-09-12
- **Final completion:** 2020-09-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066712, "Renal PK Study of LC350189". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04066712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*